NEUP
Neuphoria Therapeutics Inc. · Healthcare
Insiders bought $3.3M net in the last 90 days ·0 sellers, 1 buyer· latest Form 4 filed Oct 23, 2025
Insider Buying
$3.3M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Latest filing
Oct 23, 2025
Lynx1 Capital Management LP
Neuphoria Therapeutics Inc. (NEUP) has 1 SEC Form 4 filing (1 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Oct 23, 2025.
Inside the rolling window, 1 insider at Neuphoria Therapeutics Inc. reported 1 open-market purchase totaling $3.3M and no open-market sales. Insiders have net bought $3.3M over the trailing 6 months. The largest single insider purchase in this window was $3.3M by 10% Owner Lynx1 Capital Management LP on Oct 21, 2025.
- Industry:Biotechnology
- CEO:Spyridon Papapetropoulos
- Employees:8
- HQ:Burlington, MA, US
- IPO:2021-12-16
| Source | |||||||
|---|---|---|---|---|---|---|---|
Lynx1 Capital Management LPFirst filing | 10% Owner | Purchase | 639,110 | $3.3M | Oct 23 | — | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does NEUP have?
Neuphoria Therapeutics Inc. (NEUP) has 1 SEC Form 4 filing (1 transaction rows) in the rolling 365-day window, disclosed by 1 distinct insider. Most recent filing: Oct 23, 2025.
When was the most recent SEC Form 4 filing for NEUP?
The most recent Form 4 filing for NEUP on Tracefour is dated Oct 23, 2025.
What is the net insider flow at NEUP over the last 6 months?
Over the trailing 180 days, insiders at NEUP have net bought $3.3M based on SEC Form 4 disclosures.
What was the largest insider purchase at NEUP?
The largest single insider open-market purchase at NEUP in the rolling window was $3.3M by 10% Owner Lynx1 Capital Management LP on 2025-10-21.
What is the total insider buy and sell value at NEUP in the current window?
Inside the rolling window, insiders at NEUP bought $3.3M and sold $0 based on SEC Form 4 filings.
Can I get alerts for NEUP insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Neuphoria Therapeutics Inc. (NEUP). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Neuphoria Therapeutics Inc. is in the Healthcare sector.